ABOS
Acumen Pharmaceuticals Inc
2.20$
-3.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.5% | +12.8% | +2.3% | +0.0% | -2.2% | +2.3% | +4.4% | +0.0% | +1,474.5% | -93.8% | -500.0% | – | |
| – | +2.1% | +52.0% | -0.6% | -5.3% | +0.2% | +5.6% | +1.0% | -1.5% | -1.7% | -1.0% | +5.3% | – | |
| – | – | -167.2% | – | -0.8% | +120.2% | -189.6% | – | -212.0% | – | -291.6% | – | – | |
| – | +100.0% | -21.4% | -54.5% | -100.0% | – | – | -88.6% | -100.0% | – | – | – | – | |
| – | -46.9% | -81.1% | – | -126.9% | – | -3.3% | +34.1% | +5.3% | -35.2% | -152.6% | – | – | |
| – | – | +8,105.1% | -100.0% | – | – | +711.1% | -100.0% | – | – | – | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -76.3% | -75.6% | -101.8% | -67.2% | -78.6% | +300.0% | -100.0% | – | – | +1,787,000.0% | -100.8% | – | |
| – | -258.4% | – | – | -265.4% | – | -323.8% | – | +50.7% | -28.6% | -130.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.